title: Molecular Validation of PACE4 as a Target in Prostate Cancer.
abstract: Prostate cancer remains the single most prevalent cancer in men. Standard therapies are still limited and include androgen ablation that initially causes tumor regression. However, tumor cells eventually relapse and develop into a hormone-refractory prostate cancer. One of the current challenges in this disease is to define new therapeutic targets, which have been virtually unchanged in the past 30 years. Recent studies have suggested that the family of enzymes known as the proprotein convertases (PCs) is involved in various types of cancers and their progression. The present study examined PC expression in prostate cancer and validates one PC, namely PACE4, as a target. The evidence includes the observed high expression of PACE4 in all different clinical stages of human prostate tumor tissues. Gene silencing studies targeting PACE4 in the DU145 prostate cancer cell line produced cells (cell line 4-2) with slower proliferation rates, reduced clonogenic activity, and inability to grow as xenografts in nude mice. Gene expression and proteomic profiling of the 4-2 cell line reveals an increased expression of known cancer-related genes (e.g., GJA1, CD44, IGFBP6) that are downregulated in prostate cancer. Similarly, cancer genes whose expression is decreased in the 4-2 cell line were upregulated in prostate cancer (e.g., MUC1, IL6). The direct role of PACE4 in prostate cancer is most likely through the upregulated processing of growth factors or through the aberrant processing of growth factors leading to sustained cancer progression, suggesting that PACE4 holds a central role in prostate cancer.
authors.affiliation: Institut de Pharmacologie de Sherbrooke, Université de Sherbrooke, Sherbrooke, Québec, Canada.
authors.forename: François
authors.initials: F
authors.lastname: D'Anjou
authors.forename: Sophie
authors.initials: S
authors.lastname: Routhier
authors.forename: Jean-Pierre
authors.initials: JP
authors.lastname: Perreault
authors.forename: Alain
authors.initials: A
authors.lastname: Latil
authors.forename: David
authors.initials: D
authors.lastname: Bonnel
authors.forename: Isabelle
authors.initials: I
authors.lastname: Fournier
authors.forename: Michel
authors.initials: M
authors.lastname: Salzet
authors.forename: Robert
authors.initials: R
authors.lastname: Day